These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 4889477)

  • 1. Double-blind trial of anorectic agents.
    Sproule BC
    Med J Aust; 1969 Feb; 1(8):394-5. PubMed ID: 4889477
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of phentermine-amphetamine resin complex with sustained-release dextroamphetamine and placebo in the treatment of exogenous obesity.
    De Felice EA; Cohen A; Schmitz PL; Rothwell KG; Truant AP
    J Clin Pharmacol J New Drugs; 1968; 8(6):360-9. PubMed ID: 4883784
    [No Abstract]   [Full Text] [Related]  

  • 3. Phentermine resin as an adjunct in medical weight reduction: a controlled, randomized, double-blind prospective study.
    Truant AP; Olon LP; Cobb S
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):726-38. PubMed ID: 4629111
    [No Abstract]   [Full Text] [Related]  

  • 4. Double-blind comparison of efficacy, safety, and side effects of Bionamin, phentermine compound, and placebo in the treatment of exogenous obesity.
    Cohen A; De Felice EA; Leb SM; Fuentes JG; Rothwell KG; Truant AP
    Curr Ther Res Clin Exp; 1968 Jul; 10(7):323-34. PubMed ID: 4969672
    [No Abstract]   [Full Text] [Related]  

  • 5. [Model for clinico-pharmacological experimentation with an appetite depressant. Clinical trial with a delayed-action preparation].
    Strata A; Cucurachi L; Cucurachi P; Dell'anna A; Zuliani U
    Clin Ter; 1968 Mar; 44(6):495-516. PubMed ID: 4899457
    [No Abstract]   [Full Text] [Related]  

  • 6. Double-blind clinical evaluation of mazindol, dextroamphetamine, and placebo in treatment of exogenous obesity.
    Defelice EA; Chaykin LB; Cohen A
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):358-66. PubMed ID: 4198296
    [No Abstract]   [Full Text] [Related]  

  • 7. Double-blind trial of anorectic agents.
    Bell DS
    Med J Aust; 1969 Mar; 1(11):599-600. PubMed ID: 4889482
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinically controlled trial of Perphoxene].
    Barbey JD
    Schweiz Rundsch Med Prax; 1971 Sep; 60(37):1242-6. PubMed ID: 4937701
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of an "anorexic" drug (phentermine-resin) in the treatment of obesity].
    Benedetti A; Busonera G; Cattano G
    Policlinico Prat; 1967 Nov; 74(48):1613-9. PubMed ID: 5611163
    [No Abstract]   [Full Text] [Related]  

  • 10. A double-blind evaluation of an anorexiant, a placebo and diet alone in obese subjects.
    Resnick M; Joubert L
    Can Med Assoc J; 1967 Oct; 97(17):1011-5. PubMed ID: 6052899
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparative trial of different regimens of fenfluramine and phentermine in obesity.
    Steel JM; Munro JF; Duncan LJ
    Practitioner; 1973 Aug; 211(262):232-6. PubMed ID: 4580610
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experience with the use of phenyltert-butylamine (phentermine) as an appetite depressant in the treatment of obesity].
    Lobato DS; da Silveira DD
    Hospital (Rio J); 1966 Nov; 70(5):1343-50. PubMed ID: 5301950
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic trial of an anorectic agent using the double blind cross-over technic].
    Bienert HR; Uberla K
    Arzneimittelforschung; 1967 Mar; 17(3):336-42. PubMed ID: 4869817
    [No Abstract]   [Full Text] [Related]  

  • 14. [Phentermine resinate in obesity. Clinical trial of Mirapront in adipose children].
    Spranger J
    Munch Med Wochenschr; 1965 Sep; 107(38):1833-4. PubMed ID: 5323498
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experience with the appetite depressant, fenfluramine hydrochloride, in adiposity].
    Liebermeister H; Probst G; Jahnke K
    Med Klin; 1969; 64(26):1201-7. PubMed ID: 5807324
    [No Abstract]   [Full Text] [Related]  

  • 16. A clinical trial of fenfluramine.
    Traherne JB
    Practitioner; 1965 Nov; 195(169):677-80. PubMed ID: 5321366
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of three anorexiants. Clortermine hydrochloride (voranil), fenfluramine hydrochloride (pondimin), and mazindol (sanorex).
    Dykes MH
    JAMA; 1974 Oct; 230(2):270-2. PubMed ID: 4606535
    [No Abstract]   [Full Text] [Related]  

  • 18. Diet pill psychosis.
    Hoffman BF
    Can Med Assoc J; 1977 Feb; 116(4):351-5. PubMed ID: 844014
    [No Abstract]   [Full Text] [Related]  

  • 19. A new anorectic drug.
    Benjamin JM
    Br J Clin Pract; 1968 Aug; 22(8):350-2. PubMed ID: 4885706
    [No Abstract]   [Full Text] [Related]  

  • 20. Controlled clinical evaluation of a new anorectic agent in obese adults.
    Elmaleh MK; Miller J
    Pa Med; 1974 Sep; 77(9):46-50. PubMed ID: 4609056
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.